Literature DB >> 15211095

Pathogenesis of diabetic nephropathy.

Claudia van Dijk1, Tomas Berl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15211095     DOI： 10.1023/B:REMD.0000032412.91984.ec

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  90 in total

Review 1.  Regulation of smooth muscle contractile elements by second messengers.

Authors:  K E Kamm; J T Stull
Journal:  Annu Rev Physiol       Date:  1989       Impact factor: 19.318

2.  On the prognosis of IDDM patients with large kidneys.

Authors:  H J Baumgartl; G Sigl; P Banholzer; M Haslbeck; E Standl
Journal:  Nephrol Dial Transplant       Date:  1998-03       Impact factor: 5.992

3.  Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products.

Authors:  J Li; A M Schmidt
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

4.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

5.  Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

Authors:  M J Wiseman; A J Saunders; H Keen; G Viberti
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

6.  Abysmal prognosis of patients with type 2 diabetes entering dialysis.

Authors:  F Chantrel; I Enache; M Bouiller; I Kolb; K Kunz; P Petitjean; B Moulin; T Hannedouche
Journal:  Nephrol Dial Transplant       Date:  1999-01       Impact factor: 5.992

7.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

Authors:  Nozomu Tanji; Glen S Markowitz; Caifeng Fu; Thomas Kislinger; Akihiko Taguchi; Monika Pischetsrieder; David Stern; Ann Marie Schmidt; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

8.  Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

Authors:  T Miyata; Y Wada; Z Cai; Y Iida; K Horie; Y Yasuda; K Maeda; K Kurokawa; C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1997-04       Impact factor: 10.612

Review 9.  Role of angiotensin II in tubulointerstitial injury.

Authors:  Z Cao; M E Cooper
Journal:  Semin Nephrol       Date:  2001-11       Impact factor: 5.299

Review 10.  Contribution of polyol pathway to diabetes-induced oxidative stress.

Authors:  Stephen S M Chung; Eric C M Ho; Karen S L Lam; Sookja K Chung
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121
View more
  12 in total

1.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

2.  Long-term renal changes in the liver-specific glucokinase knockout mouse: implications for renal disease in maturity-onset diabetes of the young 2.

Authors:  Yi Gu; Yiqing Mao; Hui Li; Shuyong Zhao; Yang Yang; Hui Gao; Jianqiang Yu; Xuemei Zhang; David M Irwin; Gang Niu; Huanran Tan
Journal:  Transl Res       Date:  2010-12-13       Impact factor: 7.012

3.  Hpyerglycemic and anti-diabetic nephritis activities of polysaccharides separated from Auricularia auricular in diet-streptozotocin-induced diabetic rats.

Authors:  Xinyu Hu; Chungang Liu; Xue Wang; Dongxu Jia; Wenqian Lu; Xiaoqi Sun; Yang Liu; Lijia Yuan
Journal:  Exp Ther Med       Date:  2016-12-01       Impact factor: 2.447

4.  Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes.

Authors:  Cathy Grutzmacher; SunYoung Park; Yun Zhao; Margaret E Morrison; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-17

5.  Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.

Authors:  Christine M Sorenson; Shoujian Wang; Robert Gendron; Hélène Paradis; Nader Sheibani
Journal:  J Diabetes Metab       Date:  2013-05-25

6.  Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study.

Authors:  Jamie Morton; Sophia Zoungas; Qiang Li; Anushka A Patel; John Chalmers; Mark Woodward; David S Celermajer; Joline W J Beulens; Ronald P Stolk; Paul Glasziou; Martin K C Ng
Journal:  Diabetes Care       Date:  2012-08-13       Impact factor: 19.112

7.  Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.

Authors:  Ling Yu; Yan Su; Paisit Paueksakon; Huifang Cheng; Xiwu Chen; Hongtao Wang; Raymond C Harris; Roy Zent; Ambra Pozzi
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

8.  ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway.

Authors:  Mingxia Jiang; Haifen Zhang; Lijie Zhai; Bianliang Ye; Yin Cheng; Chengkai Zhai
Journal:  Lipids Health Dis       Date:  2017-11-16       Impact factor: 3.876

9.  Identification of biomarkers for type 2 diabetes and its complications: a bioinformatic approach.

Authors:  Srinubabu Gedela; Allam Appa Rao; Narasimha Rao Medicherla
Journal:  Int J Biomed Sci       Date:  2007-12

10.  Studies on the antidiabetic activities of Cordyceps militaris extract in diet-streptozotocin-induced diabetic Sprague-Dawley rats.

Authors:  Yuan Dong; Tianjiao Jing; Qingfan Meng; Chungang Liu; Shuang Hu; Yihang Ma; Yan Liu; Jiahui Lu; Yingkun Cheng; Di Wang; Lirong Teng
Journal:  Biomed Res Int       Date:  2014-03-11       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.